AYSHA RIZWAN: Open Payments
NPI 1053883298 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 13 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $68 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 4 | $150 |
| Gilead Sciences, Inc. | 6 | $137 |
| ABBVIE INC. | 1 | $33 |
| Novo Nordisk Inc | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $21 |
Products named: APRETUDE, QULIPTA, DOVATO, Wegovy, CABENUVA, PIFELTRO.
Industry payments across TX — which companies pay providers there.
